ExodusPoint Capital Management’s ClearPoint Neuro CLPT Stock Holding History

ExodusPoint Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,450	Closed	-$252K	–	1619
2025 Q4	$252K	Buy	+18,450	New	+$342K	﹤0.01%	1350
2025 Q2	–	Sell	-45,775	Closed	-$544K	–	1529
2025 Q1	$544K	Buy	45,775 +32,527	+246%	+$506K	0.01%	1093
2024 Q4	$204K	Buy	+13,248	New	+$172K	﹤0.01%	1361
2021 Q2	–	Sell	-45,536	Closed	-$963K	–	2403
2021 Q1	$963K	Sell	45,536 -7,647	-14%	-$164K	0.01%	937
2020 Q4	$845K	Buy	+53,183	New	+$477K	0.01%	946

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

ExodusPoint Capital Management's CLPT Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 18,450 shares — an estimated $252K sold.

ExodusPoint Capital Management first reported a position in CLPT in Q4 2020 and held it in 5 quarters. The position peaked at $963K in Q1 2021. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

ExodusPoint Capital Management reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 18,450 ClearPoint Neuro shares in Q1 2026, an estimated $252K.
ExodusPoint Capital Management first reported a position in ClearPoint Neuro in Q4 2020 and held it in 5 quarters.
ExodusPoint Capital Management's ClearPoint Neuro position peaked at $963K in Q1 2021.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.